CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
May 15, 2024 17:17 ET
|
Centogene NV
Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned...
CENTOGENE Reports First Half 2023 Financial Results
September 07, 2023 17:00 ET
|
Centogene NV
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue...
CENTOGENE Reports Full Year 2022 Financial Results
May 16, 2023 18:25 ET
|
Centogene NV
Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidanceSignificant expansion of gross profit margin from 32% to 42% and ongoing cost control...
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
December 22, 2022 16:00 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Technologies D-BOX annonce ses résultats du premier trimestre 2023
August 11, 2022 17:00 ET
|
Technologies D-BOX inc.
Une croissance forte et rentable Les revenus totaux ont augmenté de 125 % par rapport à l’année précédente pour atteindre 7,1 millions de dollars grâce à la vente de billets des films à grands succès...
D-BOX Technologies Reports First Quarter Results for FY 2023
August 11, 2022 17:00 ET
|
D-BOX Technologies Inc.
Highlighted by strong profitable growth Total revenues increased 125% year-over-year to $7.1 million, driven by ticket sales of blockbuster movies and full reopening of entertainment venuesRights for...
CENTOGENE Reports First Quarter 2022 Financial Results
July 15, 2022 08:15 ET
|
Centogene NV
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022Positioning Pharma and Diagnostics for post-COVID recovery and...
Technologies D-BOX annonce ses résultats du quatrième trimestre et de l’exercice financier 2022
June 02, 2022 17:00 ET
|
Technologies D-BOX inc.
Croissance des revenus de 92 % et BAIIA ajusté positif T4 2022 Les revenus totaux ont augmenté de 137 % par rapport au même trimestre de l’exercice précédent pour atteindre 7,0 millions de...
D-BOX Technologies Reports Fourth Quarter and Fiscal 2022 Results
June 02, 2022 17:00 ET
|
D-BOX Technologies Inc.
Delivers 92% year-over-year revenue growth and positive adjusted EBITDA Q4 2022 Total revenues increased 137% year-over-year to $7.0 millionRevenues related to systems sales improved 105%...
CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
March 30, 2022 07:30 ET
|
Centogene NV
- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million...